{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:20:06Z","timestamp":1757701206314,"version":"3.33.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2002,9,1]],"date-time":"2002-09-01T00:00:00Z","timestamp":1030838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,9,1]],"date-time":"2002-09-01T00:00:00Z","timestamp":1030838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2002,9]]},"DOI":"10.1136\/ard.61.9.859-a","type":"journal-article","created":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T19:54:10Z","timestamp":1033502050000},"page":"859-860","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Adult onset Still's disease: response to Enbrel"],"prefix":"10.1016","volume":"61","author":[{"given":"R A","family":"Asherson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Pascoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H G","family":"Kraetsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Manger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ard.61.9.859-a_bib1","first-page":"81","article-title":"Therapuetic use of single-stranded naked denatured DNA (defibrotid.DF) in antiphospholipid antibody syndrome (APLAS) [abstract]","volume":"5","author":"Burcoglu","year":"1996","journal-title":"Lupus"},{"key":"10.1136\/ard.61.9.859-a_bib2","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0140-6736(05)79252-7","article-title":"TNF-\u03b1 and response of treatment-resistant adult-onset Still\u2019s disease to thalidomide","volume":"352","author":"Stambe","year":"1997","journal-title":"Lancet"},{"key":"10.1136\/ard.61.9.859-a_bib3","first-page":"396","article-title":"Elevated serum interleukin-6, interferon-\u03b3, and tumor necrosis factor-\u03b1 levels in patients with adult Still\u2019s disease","volume":"25","author":"Hoshino","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.61.9.859-a_bib4","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/rheumatology\/36.5.589","article-title":"Suppression of fever and the acute-phase response in a patient with juvenile chronic arthritis treated with monoclonal antibody to tumour necrosis factor-\u03b1 (cA2)","volume":"36","author":"Elliott","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.61.9.859-a_bib5","first-page":"329","article-title":"Infliximab in the treatment of adult Still\u2019s disease refractory to conventional therapy","volume":"19","author":"Cavagna","year":"2001","journal-title":"Clin Exp Rheumatol"},{"issue":"suppl III","key":"10.1136\/ard.61.9.859-a_bib6","doi-asserted-by":"crossref","first-page":"iii55","DOI":"10.1136\/ard.60.90003.iii55","article-title":"Successful treatment of a small cohort of patients with adult onset of Still\u2019s disease with infliximab: first experiences","volume":"60","author":"Kraetsch","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.61.9.859-a_bib7","first-page":"285","article-title":"Efficiency of cyclophosphamide bolus in Still\u2019s disease in adults. A case","volume":"59","author":"Chaquat","year":"1992","journal-title":"Rev Rhum Mal Osteoartic"},{"key":"10.1136\/ard.61.9.859-a_bib8","first-page":"1582","article-title":"Cyclosporin A in the treatment of adult onset Still\u2019s disease","volume":"24","author":"Marchesoni","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.61.9.859-a_bib9","first-page":"113","article-title":"A case of adult onset Still\u2019s disease treated with infliximab","volume":"20","author":"Caramaschi","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.61.9.859-a_bib10","first-page":"329","article-title":"Infliximab in the treatment of adult Still\u2019s disease refractory to conventional therapy","volume":"19","author":"Cavagna","year":"2001","journal-title":"Clin Exp Rheumatol"},{"issue":"suppl III","key":"10.1136\/ard.61.9.859-a_bib11","doi-asserted-by":"crossref","first-page":"iii55","DOI":"10.1136\/ard.60.90003.iii55","article-title":"Successful treatment of a small cohort of patients with adult onset of Still\u2019s disease with infliximab: first experiences","volume":"60","author":"Kraetsch","year":"2001","journal-title":"Ann Rheum Dis"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724092598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724092598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.61.9.859-a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T04:59:08Z","timestamp":1737349148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724092598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9]]},"references-count":11,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2002,9]]}},"alternative-id":["S0003496724092598"],"URL":"https:\/\/doi.org\/10.1136\/ard.61.9.859-a","relation":{},"ISSN":["0003-4967"],"issn-type":[{"type":"print","value":"0003-4967"}],"subject":[],"published":{"date-parts":[[2002,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adult onset Still's disease: response to Enbrel","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.61.9.859-a","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 Copyright 2002 by Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}